AbbVie reports loss as COVID-19 hits Botox sales

Drugmaker AbbVie Inc reported a loss in the second quarter on Friday, as comparable sales from wrinkle treatment Botox, acquired as part of its $63 billion Allergan Plc deal, slumped due to the impact …
( read original story …)


Advertisement